» Articles » PMID: 26709677

Tumor Suppressor Role of MiR-363-3p in Gastric Cancer

Overview
Journal Med Sci Monit
Date 2015 Dec 29
PMID 26709677
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Gastric cancer (GC) is the most common cancer in the world. Despite the advancement of the treatment of GC, the 5-year overall survival rate is still very low. MicroRNAs (miRNAs) play important roles in the pathogenesis of GC. A recent study suggested that miR-363-3p plays a role in the development of GC. However, the function of miR-363-3p in GC is not fully understood. MATERIAL AND METHODS The network of NOTCH1 and the involved molecules was constructed by use of Cytoscape software. MiR-363-3p levels in GC tissues and cells were tested by qRT-PCR. Cells were miR-363-3p mimics or anti-miR-363-3p transfected by Lipofectamine. Bioinformatics algorithms from TargetScanHuman were used to predict the target genes of miR-363-3p. The NOTCH1 protein level was tested by Western blot. The interaction between miR-363-3p and NOTCH1 was confirmed by dual luciferase assays. RESULTS MiR-363-3p showed low levels in GC tissues and cells. Enforced expression of miR-363-3p inhibited cell growth and migration of GC cells and vice versa. NOTCH1 is the targeted gene of miR-363-3p. CONCLUSIONS MiR-363-3p plays a tumor suppressor role in GC.

Citing Articles

Diagnostic Value of Glycosylated Extracellular Vesicle microRNAs in Gastric Cancer.

Wang S, Ma C, Ren Z, Zhang Y, Hao K, Liu C Cancer Manag Res. 2025; 17:145-160.

PMID: 39881946 PMC: 11776422. DOI: 10.2147/CMAR.S494747.


Role of microRNA-363 during tumor progression and invasion.

Shad A, Akhlaghipour I, Alshakarchi H, Saburi E, Moghbeli M J Physiol Biochem. 2024; 80(3):481-499.

PMID: 38691273 DOI: 10.1007/s13105-024-01022-1.


Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.

Pan Y, Cengiz R, Kluiver J, Diepstra A, van den Berg A Cancers (Basel). 2024; 16(6).

PMID: 38539461 PMC: 10968648. DOI: 10.3390/cancers16061126.


Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis.

Ji Y, Gu J, Zhang H, Xu H Int J Gen Med. 2023; 16:5703-5718.

PMID: 38077476 PMC: 10710248. DOI: 10.2147/IJGM.S440340.


MiR-363 restrain the proliferation, migration and invasion of colorectal carcinoma cell by targeting E2F3.

Yang W, Yang X, Zhang Y, Li Y, Lv W J Cancer. 2023; 14(8):1362-1370.

PMID: 37283793 PMC: 10240674. DOI: 10.7150/jca.83897.


References
1.
Li D, Liu X, Lin L, Hou J, Li N, Wang C . MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem. 2011; 286(42):36677-85. PMC: 3196113. DOI: 10.1074/jbc.M111.270561. View

2.
Bauer L, Takacs A, Slotta-Huspenina J, Langer R, Becker K, Novotny A . Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study. Front Oncol. 2015; 5:94. PMC: 4406075. DOI: 10.3389/fonc.2015.00094. View

3.
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu C . microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer. 2014; 13:124. PMC: 4065091. DOI: 10.1186/1476-4598-13-124. View

4.
Hsu K, Hsieh R, Huang K, Li A, Chi C, Wang T . Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis. 2012; 33(8):1459-67. DOI: 10.1093/carcin/bgs165. View

5.
Giordano S, Columbano A . MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?. Hepatology. 2012; 57(2):840-7. DOI: 10.1002/hep.26095. View